Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corlicyte in chronic diabetic foot ulcers
NCT04104451Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2019
- Primary completion
- Aug 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of Corlicyte in diabetic foot ulcer (DFU) (3 arms), sponsored by University of Colorado Denver. Primary endpoint: Serious Adverse Events. Started Nov 2019; status: completed.
02
Drugs
Corlicyte
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04104451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04104451.